Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes
about
T cell responses to human endogenous retroviruses in HIV-1 infectionSampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptidesStructural Basis for T Cell Alloreactivity among Three HLA-B14 and HLA-B27 AntigensTwo Distinct Conformations of a Rinderpest Virus Epitope Presented by Bovine Major Histocompatibility Complex Class I N*01801: a Host Strategy To Present Featured PeptidesDistinct HIV-1 Escape Patterns Selected by Cytotoxic T Cells with Identical Epitope SpecificityBehçet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicityLong-term control of HIV-1 in hemophiliacs carrying slow-progressing allele HLA-B*5101Diverse peptide presentation of rhesus macaque major histocompatibility complex class I Mamu-A 02 revealed by two peptide complex structures and insights into immune escape of simian immunodeficiency virus.Molecular Dynamics Simulation Reveals the Selective Binding of Human Leukocyte Antigen Alleles Associated with Behçet's DiseaseVaccine Design for H5N1 Based on B- and T-cell Epitope Predictions.Genetic Analysis with the Immunochip Platform in Behçet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci.Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1HLA-B*51 and Behçet Disease.Recent advances in Takayasu arteritis.The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing.The Peptidome of Behçet's Disease-Associated HLA-B*51:01 Includes Two Subpeptidomes Differentially Shaped by Endoplasmic Reticulum Aminopeptidase 1.HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands.Purification, crystallization and preliminary X-ray diffraction analysis of the human major histocompatibility antigen HLA-B*2703 complexed with a viral peptide and with a self-peptide.Resistance-associated epitopes of HIV-1C-highly probable candidates for a multi-epitope vaccine.Identification of three novel HLA class I alleles: HLA-B*3928, HLA-B*400104 and HLA-B*4437.Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705.Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes.Examination of possible structural constraints of MHC-binding peptides by assessment of their native structure within their source proteins.Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease.HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions.General Prediction of Peptide-MHC Binding Modes Using Incremental Docking: A Proof of Concept.A biochemical and structural analysis of genetic diversity within the HLA-A*11 subtype.Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity.
P2860
Q21559508-4F3B1E75-3B03-406A-B232-5C1BD83634C9Q24651238-D1ED0162-E13D-4465-B3A4-344C508E9AF8Q27646543-78039BD9-FFF7-4212-8341-92755D5C017EQ27667354-0B404459-5717-4A85-96B3-9B9D7558E64FQ27675464-1A05E4C5-8D7C-4F54-87A3-E0D76EA8B398Q33789950-3B4D2129-E03C-4CCE-8F1A-1E45B08EA0C7Q33966626-343305C6-5F6E-4138-8ACF-1BBB07B0D053Q35077669-9507E138-101E-4AC4-8C7D-BEB4FAAC3720Q35762095-802A167A-CE3B-4461-939B-B9A519E123BCQ36009056-EE8CF79B-7B24-4B9B-8E66-21093D52BBB3Q36109098-4EC919FF-6C15-4B95-BB94-C61D31A78C60Q37080244-FD5B85A5-49E4-41E1-884F-B527D781D4E6Q37970430-34DDA80A-85B0-4A69-AEF9-F912441C7715Q38189191-518A5BB1-72FA-4554-8297-3301F9AC85A6Q38705938-AA145538-C11B-4368-ABA1-93430F502CDAQ38836084-34BA7E07-CB32-4C6A-A485-0EAAB1B28171Q40569492-1055B180-2CE1-4D16-8B4E-3BB4ABB3EA93Q41457540-ACD8D7C0-5FAE-487B-80B2-04EFFCFFEB68Q42411694-58D61EC3-EA37-4919-A317-809DADFBA815Q44734756-AFC6EF32-8751-4988-A552-FA1F12BE91DCQ45054076-595DB7DB-F7EA-4C83-9F19-184C73F2D88FQ45229475-BE850A08-1DA6-4CF9-BC8E-E3A16BF4A5EEQ46862322-7BE1DFEC-9A38-418E-8F63-3A716924A15EQ47617870-585EEA85-BEF4-42CF-9486-74AF1FB259E0Q47817333-7E6DB39D-B777-4830-9895-20611E907C57Q51199177-739340CB-FFC8-4219-AF8C-FCD35A62F9A3Q52358306-D2C92C4D-4E69-4F33-81F6-1A57C8896C6CQ53858815-2768E75A-B9A1-47F9-AB1A-74F05492E2B6Q55545340-4EF63244-9785-47C9-A868-9E22C90672E8
P2860
Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Nonstandard peptide binding re ...... th HIV immunodominant epitopes
@ast
Nonstandard peptide binding re ...... th HIV immunodominant epitopes
@en
Nonstandard peptide binding re ...... th HIV immunodominant epitopes
@nl
type
label
Nonstandard peptide binding re ...... th HIV immunodominant epitopes
@ast
Nonstandard peptide binding re ...... th HIV immunodominant epitopes
@en
Nonstandard peptide binding re ...... th HIV immunodominant epitopes
@nl
prefLabel
Nonstandard peptide binding re ...... th HIV immunodominant epitopes
@ast
Nonstandard peptide binding re ...... th HIV immunodominant epitopes
@en
Nonstandard peptide binding re ...... th HIV immunodominant epitopes
@nl
P2093
P3181
P1476
Nonstandard peptide binding re ...... th HIV immunodominant epitopes
@en
P2093
P304
P3181
P356
10.4049/JIMMUNOL.165.6.3260
P407
P577
2000-09-15T00:00:00Z